Skip to navigation menu Skip to content
Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Current Research Studies

Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in children and adolescents ? 6 to < 18 years of age

Rimegepant 311

What is the goal of the study?

To evaluate the efficacy of rimegepant compared with placebo in the acute treatment of migraine in adolescent population (? 12 to < 18 years of age) as measured by pain freedom at two hours post-dose.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: